Mengying Wu

3.9k total citations
93 papers, 2.4k citations indexed

About

Mengying Wu is a scholar working on Molecular Biology, Cancer Research and Epidemiology. According to data from OpenAlex, Mengying Wu has authored 93 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Molecular Biology, 14 papers in Cancer Research and 13 papers in Epidemiology. Recurrent topics in Mengying Wu's work include Cancer-related molecular mechanisms research (10 papers), MicroRNA in disease regulation (8 papers) and CRISPR and Genetic Engineering (7 papers). Mengying Wu is often cited by papers focused on Cancer-related molecular mechanisms research (10 papers), MicroRNA in disease regulation (8 papers) and CRISPR and Genetic Engineering (7 papers). Mengying Wu collaborates with scholars based in China, Taiwan and United Kingdom. Mengying Wu's co-authors include Li‐Yu Sung, Yu‐Chen Hu, Dongdong Lu, Qidi Zheng, Hung Li, Chun-Hung Huang, Jiahui An, Claire R. Shen, Tianming Li and Xin Gui and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and ACS Nano.

In The Last Decade

Mengying Wu

88 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mengying Wu China 25 1.6k 617 219 198 148 93 2.4k
Jianxin Lü China 36 2.2k 1.4× 550 0.9× 264 1.2× 177 0.9× 252 1.7× 96 3.3k
Hui Pan China 31 1.7k 1.0× 769 1.2× 304 1.4× 456 2.3× 151 1.0× 110 3.4k
Wenwen Wang China 30 1.5k 1.0× 304 0.5× 325 1.5× 192 1.0× 36 0.2× 161 2.7k
Ji‐Young Lee South Korea 26 1.1k 0.7× 422 0.7× 219 1.0× 341 1.7× 52 0.4× 79 2.8k
Esther G. Meyron‐Holtz Israel 26 1.2k 0.7× 175 0.3× 249 1.1× 235 1.2× 60 0.4× 52 3.7k
Xiao Han China 28 1.1k 0.7× 499 0.8× 311 1.4× 187 0.9× 86 0.6× 115 2.3k
Zhong Zhang China 28 1.2k 0.8× 173 0.3× 139 0.6× 102 0.5× 35 0.2× 161 2.5k
Xianyin Lai United States 24 815 0.5× 289 0.5× 86 0.4× 88 0.4× 41 0.3× 66 2.1k
Xiaoqing Wang China 27 1.5k 0.9× 389 0.6× 312 1.4× 165 0.8× 61 0.4× 136 2.6k
Xiaomeng Ren China 33 1.7k 1.0× 318 0.5× 386 1.8× 204 1.0× 28 0.2× 99 3.2k

Countries citing papers authored by Mengying Wu

Since Specialization
Citations

This map shows the geographic impact of Mengying Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mengying Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mengying Wu more than expected).

Fields of papers citing papers by Mengying Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mengying Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mengying Wu. The network helps show where Mengying Wu may publish in the future.

Co-authorship network of co-authors of Mengying Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Mengying Wu. A scholar is included among the top collaborators of Mengying Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mengying Wu. Mengying Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ho, Chin Yee, Mengying Wu, Sadia Ahmad, et al.. (2025). Mineral Stress Drives Loss of Heterochromatin: An Early Harbinger of Vascular Inflammaging and Calcification. Circulation Research. 136(4). 379–399. 3 indexed citations
5.
Zhang, Wenjing, Cheng Qian, Li Chen, et al.. (2024). Jujuboside A through YY1/CYP2E1 signaling alleviated type 2 diabetes-associated fatty liver disease by ameliorating hepatic lipid accumulation, inflammation, and oxidative stress. Chemico-Biological Interactions. 400. 111157–111157. 9 indexed citations
6.
Li, Ting, Jingjing Du, Mengying Wu, et al.. (2024). Harnessing HetHydrogel: A Universal Platform to Dropletize Single‐Cell Multiomics. Small Methods. 8(7). e2301631–e2301631. 5 indexed citations
7.
Wu, Mengying, et al.. (2024). Clinical Characteristics and Drug Resistance Mechanisms of Linezolid-Non-Susceptible Enterococcus in a Tertiary Hospital in Northwest China. Infection and Drug Resistance. Volume 17. 485–494. 1 indexed citations
8.
Wu, Mengying, Lingli He, Liang Yuan, et al.. (2024). The tumor suppressor NF2 modulates TEAD4 stability and activity in Hippo signaling via direct interaction. Journal of Biological Chemistry. 300(5). 107212–107212. 1 indexed citations
9.
Zhang, Wei, Mengying Wu, Rui Guo, et al.. (2024). A new long-acting analgesic formulation for postoperative pain management. International Journal of Pharmaceutics. 664. 124599–124599. 3 indexed citations
11.
Wu, Mengying, et al.. (2022). Plasma Exosomal miR-199a-5p Derived from Preeclampsia with Severe Features Impairs Endothelial Cell Function via Targeting SIRT1. Reproductive Sciences. 29(12). 3413–3424. 9 indexed citations
13.
Xia, Weiwei, Yuanyuan Li, Mengying Wu, et al.. (2021). Gasdermin E deficiency attenuates acute kidney injury by inhibiting pyroptosis and inflammation. Cell Death and Disease. 12(2). 139–139. 126 indexed citations
14.
Li, Qi, Xiaoxia Liu, Weifang Liu, et al.. (2021). MALAT1 sponges miR-26a and miR-26b to regulate endothelial cell angiogenesis via PFKFB3-driven glycolysis in early-onset preeclampsia. Molecular Therapy — Nucleic Acids. 23. 897–907. 22 indexed citations
15.
Zhang, Yang, Weifang Liu, Qi Li, et al.. (2021). Metformin Corrects Glucose Metabolism Reprogramming and NLRP3 Inflammasome‐Induced Pyroptosis via Inhibiting the TLR4/NF‐κB/PFKFB3 Signaling in Trophoblasts: Implication for a Potential Therapy of Preeclampsia. Oxidative Medicine and Cellular Longevity. 2021(1). 1806344–1806344. 54 indexed citations
16.
Sun, Zhenzhen, Yuanyuan Li, Yun Qian, et al.. (2019). Celastrol attenuates ox-LDL-induced mesangial cell proliferation via suppressing NLRP3 inflammasome activation. Cell Death Discovery. 5(1). 114–114. 16 indexed citations
17.
Huang, Hao, Yang Yang, Sheng Li, et al.. (2018). Structural analysis of fungal CENP-H/I/K homologs reveals a conserved assembly mechanism underlying proper chromosome alignment. Nucleic Acids Research. 47(1). 468–479. 19 indexed citations
18.
Li, Hung, Claire R. Shen, Chun-Hung Huang, et al.. (2016). CRISPR-Cas9 for the genome engineering of cyanobacteria and succinate production. Metabolic Engineering. 38. 293–302. 167 indexed citations
19.
Wu, Mengying, Lisette Marjavaara, Chenyi Wang, et al.. (2014). H2B Mono-ubiquitylation Facilitates Fork Stalling and Recovery during Replication Stress by Coordinating Rad53 Activation and Chromatin Assembly. PLoS Genetics. 10(10). e1004667–e1004667. 26 indexed citations
20.
Zhou, Renlai, et al.. (2014). Premenstrual syndrome is associated with blunted cortisol reactivity to the TSST. Stress. 18(2). 160–168. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026